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Abstract
Lipoxygenases (LOXs) are nonheme iron-containing enzymes
catalyzing the dioxygenation of polyunsaturated fatty acids.
LOX catalytic activity depends on the presence of iron in the
active site and the iron removal is also able to affect the
membrane binding properties of the enzyme. Leukotrienes
biosynthesis is initiated by the action of 5-LOX at the level of
nuclear membrane and the mechanism of enzyme–membrane
interaction is thought to involve structural flexibility and
conformational changes at the level of the protein tertiary
structure. In this study, we have analyzed by molecular
dynamics simulations the conformational changes induced by
iron removal in 5-LOX. The data indicate that the degree of
enzyme flexibility is related to the presence of iron into the
active site that is able to stabilize the protein increasing its
rigidity. These findings provide further evidence that the
conformation and the functional activity of LOXs is tuned by
the presence of iron at the active site, suggesting new
approaches for the design of enzyme inhibitors. C© 2017
International Union of Biochemistry and Molecular Biology, Inc. Volume 00,
Number 0, Pages 1–8, 2017
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1. Introduction
The molecular dynamics (MD) that controls the biologi-
cal function of a protein strictly depends on the fine balance
between the external interactions of surface groups with the
solvent and the intramolecular forces. In the structural and
functional study of the protein–lipid interactions, cytosolic en-
zymes able to translocate to membranes in response to specific
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stimuli could play a pivotal role. An important group of cy-
tosolic enzymes able to use lipids and biological membranes as
substrates is the lipoxygenase (LOX) family. These proteins are
nonheme, nonsulfur iron-containing enzymes, which catalyze
the dioxygenation of polyunsaturated fatty acids containing one
or more pentadiene systems to the corresponding hydroperoxy
derivatives. The available crystal structures of LOXs indicate
single polypeptide chain proteins adopting a two-domain fold-
ing: the N-terminal “C2-like” domain proposed to be involved in
bringing the enzyme in proximity to its arachidonate substrate
within the nuclear membranes [1] and the larger catalytic
C-terminal domain, that is, primarily α-helical and harbors the
nonheme catalytic iron [2].
Some mammalian LOXs are activated by a Ca2+-mediated
translocation from plasma membranes to nucleus upon cell
stimulation [3], and the translocation of 5-LOX is assisted
by a 5-LOX activating protein (FLAP) [4]. The amount of
apo-form of the enzyme found has been previously docu-
mented in several mammalian cells [5, 6]. An approach to
elucidate the structure–function relationship in metalloen-
zymes is the extraction, reconstitution, and substitution of the
central coordinated metal [7, 8]. This methodology has not
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been successful with some LOX enzymes but iron extraction
from porcine leukocyte 12-LOX [9] and soybean LOX-3 [10]
was reported. Also from the C-terminal fraction of soybean
LOX-1 (miniLOX) [11] iron was removed and a partial ac-
tivity recovery on the metal-reconstituted/substituted forms
of miniLOX was obtained [12]. In particular, it was demon-
strated that iron ion stabilizes the structure of LOX and its
presence is also crucial for themembrane binding of the enzyme
[12].
In this study, we evidenced byMD analysis that the presence
of iron within the active site stabilizes the conformation of
the human 5-LOX. These results are in line with previous
data obtained with LOX-1 from soybean [12] and confirm a
crucial role for iron in preserving the structural stability and
membrane binding ability of the enzyme. The here reported
conformational change between the apo- and holo-5-LOXmight
contribute in vivo to the 5-LOX trafficking among different
compartments of the cell, thus leading to a modulation of its
signaling.
2. Materials and Methods
2.1. Molecular models
All human 5-LOX models used in this work are based in
the X-ray crystallographic structure of stable 5-LOX mu-
tant human enzyme at 2.4 A˚ of resolution [2]. Specifically,
5-LOX K653K654K655 amino acids from the human enzyme were
replaced with the E653N654L655 sequence (KKK→ENL substi-
tution) to stabilize the enzyme. Stable-5-LOX is made of two
similar chains containing each one two distinct domains: the
N-terminal “C2-like” domain with about 120 amino acids and
the larger catalytic domain, mainly alpha-helical (550 amino
acids). The latter is harboring the active site containing a
nonheme catalytic iron (Fe2+) coordinated by three histidines
(His367,372,550), as well as the main-chain carboxylate of the C
terminus (Ile673).
The simulated systems consisted of two different molecular
structures built to model both the holo-form of stable 5-LOX
enzyme and its apo-form, where the two iron metal atoms were
removed from their active site. The holo- and apo-forms of
5-LOX enzyme model systems are made of the main protein
solvated with 52,308 and 50,177 water molecules, respectively.
TIP3P model was used to represent explicit water molecules
[13].
2.2. Parameterization of the active site
The active site model, containing Fe2+ ion, was parameterized
starting from stable crystal structure of 5-LOX to obtain the
force field parameters. Figure 1b shows truncated structure
of stable-5-LOX enzyme active site. The four amino acids lying
on the first coordination sphere of iron were truncated to their
most relevant parts; histidines and isoleucine are represented
by ethyl imidazole rings and methyl-isoleucine, respectively.
The parameters of the active site were obtained by means of the
MCPB method developed by Peters and colleagues [14], which
FIG. 1
(a) Structural model of 5-LOX dimer with its active
site highlighted in one of the enzyme monomers
and (b) truncated model of the active site.
is embedded into the MTK++ software package in AMBER
2016 [15]. MCPB is a semiautomatic method based on bonded
models for representing the interactions between metal and
its coordinating sphere of amino acids. Thus, bond, angle, and
electrostatic terms were parametrized meanwhile dihedral
terms were ignored under the assumption made by Hoops and
colleagues [16] based on the rigidity of the metal ions geometry,
which are devoid of any significant torsional rotation. More
specifically, the active site model (Fig. 1b) was subjected to a
quantum mechanical constrained geometry optimization in gas
phase using Gaussian 03 [17] program at B3LYP/6-31G* level.
Geometry parameters were derived from equilibrium values
of bond lengths and angles involving Fe2+ and its coordination
sphere of amino acids. Force constants were determined using
themethod described by Seminario [18] from submatrices of the
Cartesian Hessian matrix. The atom-centered partial charges
were derived using the restrained electrostatic potential (RESP)
schemes [19] using a large active site model by capping each
of the methyl groups with acetylamide and N-methylamide
groups, and apply the same level of quantum mechanics (QM)
calculation to derive the RESP charge parameters. Moreover,
if Fe2+ ion is buried within the protein, then the Lennard-
Jones parameters are not as important as the electrostatics
[20], so those being taken from the literature [21]. The MCPB
method has been widely used in previous studies to facilitate
the modeling of metal effects of the metalloproteins [22–24].
2.3. MD protocol
Classical MD simulations were performed on both holo- and
apo-forms of human 5-LOX enzyme using explicit solvent and
periodic boundary conditions. The ff14SB AMBER force field
[25] for the protein was applied and updated with previous
active site parameterization values. The AMBER 2016 program
[15] was used in all classical simulations. The system prepa-
ration and final production run have been the same for the
two models. Initially, the system was equilibrated by keeping
protein restrained to initial position using quadratic harmonic
restraints with a constant force of 20 kcal mol−1 A˚−2. Each
system was subjected to 2.5 × 104 minimization steps, using
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FIG. 2
Force field parameters of Fe2+ center in 5-LOX.
the MM Hamiltonian to remove any atomic contact, and then
heated to 298 K for 60 pSec at constant volume. The numerical
integration step was set to 2.0 fSec, and the Langevin thermo-
stat was used with a 5.0 pSec−1 collision frequency. The system
was allowed to relax for an additional 500 pSec using an NPT
ensemble at 298 K and 1 atmosphere of pressure. In all cases,
the bond lengths involving hydrogen atoms were kept at their
equilibrium distance by means of the SHAKE algorithm [26].
Atom pair distance cutoffs were applied at 10.0 A˚ to compute
the van der Waals interactions. Long-range electrostatics was
computed by means of the particle mesh Ewald method [27].
The harmonic restraints on the solute atoms were released and
an additional trajectory was obtained, up to constant density,
under the same conditions previously described for 5 nSec.
Finally, the production series were obtained using an NVT
ensemble at 298 K for 100 nSec. The coordinates of production
trajectories were saved at 20 pSec intervals for subsequent
analysis.
3. Results and Discussion
3.1. Parameterization of the iron active site
The iron coordination sphere is very similar in most of the
known LOX structures [3], adopting a pseudooctahedral ge-
ometry [28]. A remarkable feature of the coordination sphere
in this enzyme is the utilization of the main chain carboxy-
terminus as an iron ligand. The iron cluster optimization of
5-LOX active site, performed using the MCPB method, leads
to a similar structure to the crystallographic data but the
carboxylate moiety of Ile673 is presented as a bidentate ligand
with a bond distance of 2.001 A˚ (Fig. 1). A sketch of the new
parameterization for the first amino acid coordination sphere
is shown in Fig. 2 (all the parameters are listed in the Sup-
porting Information). A shorter bond distance (d 0.15–0.25
A˚) between the metallic ion and the ligands is derived from
iron cluster optimization and compared with crystallographic
data. Moreover, a charge reorganization on the iron ligands
is observed with a resulting positive partial charge of +0.975
a.u. for the Fe2+, meanwhile the three His and Ile residues, in
direct contact with iron, are holding a partial charge ranging
from –0.347 to –0.673 a.u., respectively.
We performed 100 nSec explicit water MD simulations in
order to differentiate the behavior between the apo- and the
holo-forms of 5-LOX systems. Initially, the root mean standard
deviation (RMSD) of all the protein backbone atoms in both
systems was obtained in order to monitor the protein structure
fluctuations from initial structure (see Fig. 3). Both systems
reached their equilibria very quickly, and after 20 nSec no
much large fluctuations were observed. Thus, in the absence
of Fe2+ ion, the stability is not apparently different from that
of holo-form of 5-LOX system. However, when the RMSD of
the atoms belonging only to the first amino acid sphere that
are linked to the iron center is considered (see Fig. 3), a large
conformational differences in the apo-form are observed and
compared with the RMSD graph of the holo-form of 5-LOX
protein. Then, the impact of metal removal in the system will
be studied in this work.
3.2. Interdomain motion
Hammel and colleagues [29] reported a high degree of mo-
tional freedom of the N-terminal β-barrel domain of 15-LOX
in aqueous solutions, which might be of importance for regu-
lation of the catalytic activity and membrane binding. These
observations were based on a bigger molecular volume of
the N-terminal β-barrel domain and on a bending of the
enzyme molecule in solution that was not observed in the
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FIG. 3
Root mean square deviation of backbone atoms
(blue line) and active site atoms (brown line) of
5-LOX dimer from the initial structures of the
enzyme (a) without iron content (apo-form of
5-LOX) and (b) with iron content (holo-form of
stable 5-LOX).
crystal structure. The interdomain motion differences between
apo- and holo-5-LOX proteins was verified by the evaluation of
the bending and movement study on the N-terminal domain by
considering the unstructured stretch of amino acids 111–119
(random coil) as an interdomain linker. Therefore, three aver-
aged parameters were extracted from the whole MD trajectory
to explore such motion between domains: the distance between
the center of mass of N-terminal domain and the center of
mass of C-terminal domain of 5-LOX protein (dCMNC-Domain), the
distance between N-terminal and C-terminal of 5-LOX protein
(deeNC-Domain), and the bending angle between the center of mass
of N-terminal domain (residues 1–110) to the center of mass of
interdomain linker (residues 111–119) to the center of mass of
C-terminal domain (residues 120–669), denoted as αCMNC-Domain.
Table 1 lists the averaged values derived from MD trajectory,
and Fig. 4 shows the fluctuation in the central bending of both
solvated 5-LOX systems. There is no significant difference for
the distances between the centers of mass of N-terminal and
C-terminal domains of both apo- and holo-forms. Also, the
end-to-end distances between domains are slightly different
possibly due to the flexibility that presents the C-terminal on
the apo-form, which is not being linked to the central coor-
dination metal ion. Thus, no appreciable linear movement of
the entire N-terminal β-barrel domain going away from the
catalytic subunit was observed during in-solvent simulation of
both systems. However, a slight difference of 1.6 A˚ was obtained
in the deeNC-Domain distance between both forms.
On the other hand, the bending angle observed between
the two domains within each 5-LOX monomer is around 85.6◦
and 85.3◦ for the apo- and the holo-forms, respectively. A
slight difference of about half degree is obtained with a more
pronounced and less dispersed frequency of occurrences
from the interdomain angle distribution on the holo-form of
stable-5-LOX protein. Similarly, calculated root mean square
fluctuations of backbone atoms, averaged over the last 50 nSec
of simulation (not shown), present a little larger deviations for
the residues of β-barrel domain, showing thus an apo-form
a little more flexible than the holo-form. The bending on the
β-barrel domain, articulated by a random coil section, leads
TABLE 1
Averaged interdomain motion values between N-terminal and C-terminal domains.Values derived from apo- and holo-forms of
5-LOX MD trajectories. Standard error of the mean is also shown.
apo-5-LOX holo-5-LOX
mon Aa mon Bb dimer mon Aa mon Bb dimer
dCMNC-Domain (A˚) 42.4 ± 0.0 42.1 ± 0.0 42.3 ± 0.0 42.4 ± 0.0 42.8 ± 0.0 42.6 ± 0.0
deeNC-Domain (A˚) 47.5 ± 0.0 48.8 ± 0.1 48.2 ± 0.1 48.9 ± 0.0 50.6 ± 0.0 49.8 ± 0.1
αCMNC-Domain (◦) 86.1 ± 0.1 85.2 ± 0.0 85.6 ± 0.1 84.8 ± 0.0 85.8 ± 0.0 85.3 ± 0.1
aMonomer A from 3O8Y PDB file;
bMonomer B from 3O8Y PDB file
Values derived from apo- and holo-forms of 5-LOX MD trajectories. Standard error of the mean is also shown.
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FIG. 4
Histogram analysis of the angle between
N-terminal and C-terminal catalytic domain
(αCMNC-Domain) of (a) apo-form and (b) holo-form of
5-LOX.
to stretching of the enzyme molecule but may also induce a
bending of the overall shape.
3.3. Solvent accessible surface
Protein–protein interfaces can be defined based on the change
in their solvent accessible surface (SAS) on a dimerization
process [30]. SAS is a measure typically used to quantify the
degree to which the solvent can interact with different parts of
the protein. In this work, theSAS will be used to determine the
protein–protein interface extension between both monomers
of the 5-LOX dimer (SASIntf-dim), and the domain–domain
interface extension between the N-terminal domain and the
catalytic C-terminal domain in both monomers (SASIntf-NCmonA
and SASIntf-NCmonB) defined as follows:
SASIntf−dim = 1/2
(
SASmonA + SASmonB − SASdimer
)
SASIntf−NCmonA = 1/2
(
SASNterm monA + SASCterm−monA − SASmonA
)
SASIntf−NCmonB = 1/2
(
SASNterm monB + SASCterm−monB − SASmonB
),
(1)
where the N-terminal domain are defined by residues 1 up to
114 and C-terminal domain from residue 115 up to 669.
TABLE 2
Averaged accessible surface area (A˚2, SAS) buried
within the interface of the dimer and the interface
between N-terminal and C-terminal domains.Values
derived from apo- and holo-forms of 5-LOX MD
trajectories. Standard error of the mean is also shown.
apo-5-LOX holo-5-LOX
SASIntf-dim 1,134 ± 3 1,133 ± 4
SASIntf-NCmonA 1,268 ± 2 1,285 ± 3
SASIntf-NCmonB 1,100 ± 3 1,113 ± 3
Values derived from apo- and holo-forms of 5-LOX MD trajectories.
Standard error of the mean is also shown.
Comparison of average SAS on the apo- and holo-forms
of stable 5-LOX systems computed from MD simulation results
(last 50 nSec) are listed in Table 2. The absence of Fe2+ ion
does not lead to any important difference in the buried surface
of stable 5-LOX dimer, with values of 1134 A˚2 (4.1 % of
the total solvent accessible area of each monomer). However,
N-terminal β-barrel domain presents a lower buried surface in
contact with the catalytic C-terminal domain in the apo-form
(1.2% decrease in the buried surface), suggesting a bit larger
interdomain motion when is compared with the holo-form. This
result is qualitatively consistent with previous section when a
little more flexible apo-form was observed.
3.4. Clustering analysis
A different time evolution of conformations on the coordination
sphere of amino acids linked to the Fe2+ ion in the apo-form
has been previously observed (Fig. 3). In this section, a more
detailed study on the structural difference between the active
site of apo- and holo-forms of stable 5-LOX enzyme is performed
by means of clustering analysis. The well-known density-based
spatial clustering analysis with noise algorithm, which classifies
particles in the MD snapshot into clusters based on particle
density variations, was used to group similar structures [31].
The postprocessing of trajectories was carried out using the
cpptraj program from the AMBER 2016 package [15].
The metrics used to obtain ligand dispersion measurement
between amino acids in the coordination sphere of Fe2+ ion is
the one-to-all averaged distance between their atom ligands
(das, Eq. (2)):
das = 13 (dHis372@N−His550@N + dHis372@N−His367@N + dHis372@N−Ile673@O)
(2)
Table 3 lists das distance for the most populated rep-
resentative clusters. The holo-form of stable- 5-LOX system
presents a pseudooctahedral geometry with a das value of 3
A˚. However, the highly populated cluster representatives of
apo-form presents a much large das value with a range of
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TABLE 3
Population of cluster representatives as a fractional
value (χ , only populations higher than 5%) and
averaged distance between atom–ligands (das in A˚)
from apo- and holo-forms of 5-LOX MD trajectories
apo-5-LOX holo-5-LOX
AS1 AS2 AS1 AS2
Cluster χ das χ das χ das χ das
c0 0.620 6.34 0.541 6.42 0.970 2.98 0.694 3.08
c1 0.362 7.29 0.120 6.41 0.021 3.06 0.296 2.94
c2 0.108 6.94
c3 0.055 6.40
distances between 6.3 up to 7.3 A˚. A close inspection to the
cluster representatives (Fig. 5) shows some dispersion, mainly
located on the carboxylic moiety of the Ile673 residue due its
easy mobility as a C-terminal residue. The three His residues
do not suffer such a large dispersion due to a general structural
stability observed during in-solution simulation of the apo-form
but there is an appreciable increase between nitrogen–ligand
atoms distances.
Fuchs and colleagues [32] reported that the release of iron
ions on some LOX-catalyzed transformations might be caused
by modifications of histidine residues located at the active
site of the enzyme. The presence of three labile histidines on
the LOX enzyme may be affected by active site modifications
and thus causing iron release and LOX inactivation [33]. In
fact, the importance of the three histidines of 5-LOX active
site was previously reported by Zhang and colleagues [34],
determining that His372 and His550 constitute two of the iron
ligands in 5-LOX as well as the necessity of His367 presence for
the enzyme activity, although the latter residue is not crucial
for iron binding. The distance between nitrogen–ligand atoms
of His372 and His550, on the representative structure of the
most populated cluster, rises from 2.92 A˚ up to 4.83 A˚ for
the as1 of holo- and apo-forms, respectively, when iron ion is
removed from the active site. The observed dispersion on the
two main iron ligands might explain the difficult to recovery
5-LOX activity when the apo-form is reconstituted with the lost
iron metal center [9, 10, 12].
3.5. Closest waters
The presence of water molecules in the coordination sphere of
Fe2+ ion in the LOX active site is believed to play an important
role in the catalytic mechanism of LOX in its active Fe3+ form
[35]. However, water molecules in 5-LOX are not so tightly
coordinated to the iron such as the 12-LOX with 2.2 A˚ of
coordination distance reported from X-ray structure [36].
Indeed, crystallographic structure of 5-LOX [2] shows one
coordination distance of 3.6 A˚ in monomer A only, and no
coordination in monomer B (first water at 5.75 A˚), meanwhile
FIG. 5
(a) Representative cluster conformations of
holo-form of 5-LOX with a population higher than
5% at 298 K during the last 50 nSec of simulation.
Representative examples of each active site (as1
and as2) are shown. (b) Representative cluster
conformations of apo-form 5-LOX with a
population higher than 10% at 298 K during the last
50 nSec of simulation. Representative examples of
each active site (as1 and as2) are shown.
15-LOX enzyme does not presents water coordination with
the first water being at 5.8 A˚ from the Fe2+ ion. Xu and
colleagues [36] pointed that the structures of the iron sites in
different LOX enzymes can be very different, which in turn
might reinforce the notion that the potential flexibility of the
iron ion and its coordination sphere structure could be relevant
to catalysis. This latter observation was based on the observed
rearrangement in the coordination sphere of the nonheme iron
atom in the activation process [37].
In this work, water molecule presence in the coordination
sphere of Fe2+ ion was explored by means of radial distribution
function (RDF), evaluated for the Fe2+ ion and oxygen atom of
water molecules depicted in Fig. 6. Attending to the different
water location observed from crystallographic data, two differ-
ent gFe-O RDF plots were derived, one at each monomer active
site. The gFe-O RDF of monomer A (as1, Fig. 6a) shows a first
peak at 4.05 A˚ and a second peak at 5.25 A˚. Integration of the
RDF (running number n(r)) up to first peak corresponds to 0.5
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FIG. 6
Radial distribution function between Fe2+ and
oxygen atoms of water molecules (blue line) on
the two active sites of 5-LOX (as1 on the left and
as2 on the right). Running number of water
molecules is also shown (brown line).
water molecules bounded to Fe2+ ion and 2.5 water molecules
up to the second peak. On the other hand, monomer B (as2,
Fig. 6b) shows a first peak at 2.60 A˚ and a second peak at 4.35
A˚ with 0.2 and 1.0 water molecules in average bounded to
metallic ion during MD trajectory for the first and second peak,
respectively. This result agrees qualitatively with the crystallo-
graphic data, showing similar differences in the coordination
distances of water between both monomeric units of 5-LOX.
However, dynamical simulation in-solution of dimeric enzyme
leads to a closer location of water molecules to the active sites
(4.0–4.3 A˚) than those reported from crystallographic data.
Moreover, some water molecules were found to be, with a mean
distance of 2.6 A˚, tightly coordinated with iron ion that might
be precursor of activation process of the enzyme. This value
corresponds to an intermediate distance between Fe2+ and
its coordinated water observed in 12-LOX (2.2 A˚) and 5-LOX
(3.6 A˚) [36].
4. Conclusions
In this paper, we studied the impact of Fe2+ ion on stable
5-LOX enzyme structure using comparative MD simulation
between the holo- and apo-forms, obtaining the latter after
removal of central iron. The force field parameters of Fe2+
were calculated by the MCPB method to obtain 100 nSec of MD
trajectory. System dynamics shows a similar RMSD evolution
for the backbone atoms of the protein on the two simulated
systems, with differences mainly located on the amino acid
coordination sphere where the apo-form presented a much
more dispersive behavior.
The motional flexibility of the N-terminal β-barrel domain
was verified by the central bending of LOX in solution. The
overall dynamics showed a slightly different half degree,
with a more pronounced and less dispersed frequency of the
interdomain angle distribution of holo-form. The SAS study
also corroborates this observation, thus suggesting a larger
interdomain motion in the apo-form when compared with
the holo-form. However, these data do not support the large
conformational change previously suggested by Hammel and
colleagues in mammalian 15-LOX [29]. Rather, the 5-LOX
conformational flexibility reported here appears more in line
with previous data demonstrating an increased rigidity of plant
and a mammalian LOX protein when inhibitors are present
in their active site, paralleled by impaired membrane binding
ability [38].
Cluster analysis of the holo- and apo-5-LOX enzyme active
sites shows an appreciable dispersion on the apo-form active
site, mainly located on the carboxylic moiety of the C-terminal
residue, Ile673. Moreover, the distance between nitrogen–ligand
atoms of His372 and His550 within the active site increases
about 2 A˚ when iron ion is removed, which might cause
a conformational change that leads to different membrane
binding properties of the apo-form.
Analysis on the water population dynamics nearby the
holo-form active site showed a closer distance to the active
sites in average than those reported on crystallographic data.
In fact, in some cases it was observed water molecules tightly
coordinated with iron ion that might act as a precursor of
activation process of the enzyme.
In a site-directed mutagenesis study aimed at investigating
the intracellular distribution of 5-LOX, it has been observed that
mutations known to abolish enzyme activity, but leaving (at least
in part) iron in the active site, induced a graded distribution of
5-LOX in the nucleus and cytosol, depending on the iron content
[39]. We already provide evidence that the presence of iron
within the active site stabilizes a conformation of LOX more
suitable for the association with model membranes [12] and the
here reported MD results seem to confirm a crucial role for iron
in preserving the structural stability and membrane binding
ability of the enzyme. Being the presence of an apo-form of
the enzyme previously documented in several mammalian
cells, this might eventually contribute in vivo to the 5-LOX
trafficking among different compartments of the cell, and hence
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modulating signaling thereof. A typical pathological feature of
Alzheimer’s disease (AD) is the appearance in the brain of
senile plaques, made up of aggregates of misfolded β-amyloid,
associated with an abnormal accumulation of some metal ions,
including iron [40]. In this context, we have recently shown an
increase in 5-LOX mRNA and protein levels, as well as enzyme
activity, in late onset AD subjects compared to healthy controls
[41], and consistently, here we show a significant role of iron in
the structural and functional stabilization of 5-LOX. Thus, here
we are speculating that our in silico structural results could be
of relevance for the role of LOXs in inflammatory diseases and
neurodegeneration with altered iron homeostasis, but also in
neurodegeneration such as AD, where the activity of 5-LOX is
indeed remarkably increased [42].
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